Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Antiviral Agents And Vaccines Against Influenza

  • Read more about Antiviral Agents And Vaccines Against Influenza
US Application 12/279,332
Filed on 2008-08-13

Use Of Chimeric HIV/SIV Gag Proteins To Optimize Vaccine-Induced T Cell Responses Against HIV Gag

  • Read more about Use Of Chimeric HIV/SIV Gag Proteins To Optimize Vaccine-Induced T Cell Responses Against HIV Gag
Patent Cooperation Treaty
PCT/US2008/073395
Filed on 2008-08-15

P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE

  • Read more about P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE
Japan
2008-251982
Filed on 2008-09-30

Detection Of Infectious Prion Protein By Seeded Conversion Of Recombinant Prion Protein

  • Read more about Detection Of Infectious Prion Protein By Seeded Conversion Of Recombinant Prion Protein
US Patent 8,216,788
Filed on 2008-07-21

PSEUDOTYPED VIRAL VECTORS AND METHODS OF MAKING AND USING

  • Read more about PSEUDOTYPED VIRAL VECTORS AND METHODS OF MAKING AND USING
Patent Cooperation Treaty
PCT/US2008/075853
Filed on 2008-09-10

PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
Japan
2008-184327
Filed on 2008-08-18

Methods for Detections and Prevention of Tick Infestation and Pathogen Transmission

  • Read more about Methods for Detections and Prevention of Tick Infestation and Pathogen Transmission
Patent Cooperation Treaty
PCT/US2008/009075
Filed on 2008-07-25

Treatment Of Primary Tumors And Tumor Metastases With TNF-alpha Antagonists

  • Read more about Treatment Of Primary Tumors And Tumor Metastases With TNF-alpha Antagonists
Patent Cooperation Treaty
PCT/US2008/071736
Filed on 2008-07-31

Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses

  • Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses
India
204/DELNP/2005
Filed on 2005-01-19

AEGYPTIN AND USES THEREOF

  • Read more about AEGYPTIN AND USES THEREOF
Patent Cooperation Treaty
PCT/US2008/069349
Filed on 2008-07-07

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 391
  • Page 392
  • Page 393
  • Page 394
  • Page 395
  • Page 396
  • Page 397
  • Page 398
  • Page 399
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health